These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

398 related items for PubMed ID: 29589067

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Clozapine Rechallenge After Major Adverse Effects: Clinical Guidelines Based on 259 Cases.
    Manu P, Lapitskaya Y, Shaikh A, Nielsen J.
    Am J Ther; 2018; 25(2):e218-e223. PubMed ID: 29505490
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Incidence and risk factors for clozapine-induced myocarditis and cardiomyopathy at a regional mental health service in Australia.
    Youssef DL, Narayanan P, Gill N.
    Australas Psychiatry; 2016 Apr; 24(2):176-80. PubMed ID: 26400457
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Systematic review and meta-analysis of rates of clozapine-associated myocarditis and cardiomyopathy.
    Siskind D, Sidhu A, Cross J, Chua YT, Myles N, Cohen D, Kisely S.
    Aust N Z J Psychiatry; 2020 May; 54(5):467-481. PubMed ID: 31957459
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Reaction on 'Myocarditis and cardiomyopathy underestimated complications resulting from clozapine therapy'].
    Schulte PF.
    Tijdschr Psychiatr; 2011 May; 53(3):193-4. PubMed ID: 21404176
    [No Abstract] [Full Text] [Related]

  • 12. [Reaction on 'Myocarditis and cardiomyopathy underestimated complications resulting from clozapine therapy'].
    Cohen D.
    Tijdschr Psychiatr; 2010 May; 52(10):727-8; author reply 728-9. PubMed ID: 20931487
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Chart review for potential features of myocarditis, pericarditis, and cardiomyopathy in children and adolescents treated with clozapine.
    Wehmeier PM, Schüler-Springorum M, Heiser P, Remschmidt H.
    J Child Adolesc Psychopharmacol; 2004 May; 14(2):267-71. PubMed ID: 15319023
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Incidence and investigation of potential risk-factors for clozapine-associated myocarditis and cardiomyopathy in a New Zealand cohort.
    Bellissima BL, Vara A, Helsby N, Garavan F, Tingle MD.
    Psychiatry Res; 2021 May; 299():113873. PubMed ID: 33799127
    [Abstract] [Full Text] [Related]

  • 17. Myocarditis after administration of clozapine.
    Kontoangelos K, Loizos S, Kanakakis J, Smyrnis N, Economou M, Bergiannaki JD, Papadimitriou GN.
    Eur Rev Med Pharmacol Sci; 2014 Aug; 18(16):2383-6. PubMed ID: 25219841
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Adverse cardiac events in out-patients initiating clozapine treatment: a nationwide register-based study.
    Rohde C, Polcwiartek C, Kragholm K, Ebdrup BH, Siskind D, Nielsen J.
    Acta Psychiatr Scand; 2018 Jan; 137(1):47-53. PubMed ID: 29064084
    [Abstract] [Full Text] [Related]

  • 20. Cardiovascular disease in patients with schizophrenia.
    Kritharides L, Chow V, Lambert TJ.
    Med J Aust; 2017 Feb 06; 206(2):91-95. PubMed ID: 28152356
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.